NASDAQ
Alseres Pharmaceuticals, Inc. (ALSE) has a fcf yield of -234.32% as of Monday, August 3, 2026. This represents a 47.86% decrease compared to its 12-month average of -158.47%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.